Bilal Shafi, M.D.
Cardiothoracic & Endovascular Surgeon | Healthcare Innovator

Dr. Bilal Shafi is a distinguished cardiothoracic and endovascular surgeon with a track record of pioneering advancements in complex cardiac, aortic, and thoracic procedures. With over two decades of experience, he has played a pivotal role in developing regional cardiovascular programs and driving surgical innovation.

Professional Highlights

• Chief of Cardiac Surgery, Dominican Hospital (2014–Present)
  • Tripled cardiac surgical volume from 80 to 240 cases per year.
  • Established the Central Coast’s first Structural Heart Program (TAVR, MitraClip) and ECMO Center of Excellence.
  • Developed a regional Thoracic Aortic Center, introducing advanced endovascular and open procedures.
  • Founded San Francisco Bay Area’s only Robotic Cardiac Surgical Valve Program, performing 400 robotic mitral, tricuspid, and multivalve procedures.
  • Launched Central Coast’s first Robotic Thoracic Surgery Program, completing over 500 cases to date.
• Director of Cardiovascular Surgery & Structural Heart, Good Samaritan Hospital (2016–Present)
  • Led introduction of complex aortic surgeries, including valve-sparing root replacements.
  • Spearheaded the development of hybrid atrial fibrillation ablation programs.
  • Standardized post-op management, reducing length of stay and improving patient outcomes.
• Palo Alto Medical Foundation (PAMF), Sutter Health (2014–Present)
  • Performs 350–400 cardiothoracic procedures annually, specializing in minimally invasive and robotic-assisted surgery.
  • Leads cardiovascular program development and operational strategy for South Bay Region.

Academic & Research Excellence

• Fellowships: Cardiothoracic Surgery & Endovascular Surgery, University of Pennsylvania
• M.D.: Jefferson Medical College, Thomas Jefferson University
• M.S.E. Bioengineering: University of Pennsylvania
• Awarded MIT Technology Review’s TR35, recognizing top 35 innovators under 35.
• Principal Investigator (PI) on multiple NSF & NIH research grants, securing over $1 million in funding.
• Published extensively in leading medical journals, contributing to advancements in biomaterials, surgical innovation, and patient care.

Dr. Shafi’s expertise in complex surgical interventions, program development, and medical innovation has solidified his reputation as a leader in modern cardiothoracic surgery. His commitment to patient care, surgical excellence, and innovation continues to shape the future of cardiovascular medicine.